Choline Magnesium Trisalicylate
Generic name: Pronounced as (koe' leen) (mag nee' zhum)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 07/15/2018
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
Why is this medication prescribed?
Choline magnesium trisalicylate is used to relieve the pain, tenderness, inflammation (swelling), and stiffness caused by arthritis and painful shoulder. It is also used to relieve pain and lower fever. Choline magnesium trisalicylate is in a class of nonsteroidal anti-inflammatory medications (NSAIDs) called salicylates. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.
How should this medicine be used?
Choline magnesium trisalicylate comes as a tablet and a liquid to take by mouth. It is usually taken one to three times a day. To help you remember to take choline magnesium trisalicylate, take it around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take choline magnesium trisalicylate exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking choline magnesium trisalicylate,
-
tell your doctor and pharmacist if you are allergic to choline magnesium trisalicylate, aspirin, choline salicylate (Arthropan), diflunisal (Dolobid), magnesium salicylate (Doan's, others), salsalate (Argesic, Disalcid, Salgesic), or any other medications.
-
tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: acetazolamide (Diamox); antacids; anticoagulants ('blood thinners') such as warfarin (Coumadin); dichlorphenamide (Daranide); insulin and oral medications for diabetes such as acetohexamide (Dymelor), chlorpropamide (Diabinese), glimepiride (Amaryl), glipizide (Glucotrol), glyburide (DiaBeta, Glynase, Micronase), tolazamide (Tolinase), and tolbutamide (Orinase); medications for gout such as probenecid (Benemid) and sulfinpyrazone (Anturane); methazolamide (GlaucTabs, Neptazane); methotrexate (Rheumatrex); oral steroids such as dexamethasone (Decadron, Dexone), methylprednisolone (Medrol), and prednisone (Deltasone); other salicylate pain relievers such as aspirin, choline salicylate (Arthropan), diflunisal (Dolobid), magnesium salicylate (Doan's, others), and salsalate (Argesic, Disalcid, Salgesic); phenytoin (Dilantin); and valproic acid (Depakene, Depakote). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor if you have or have ever had stomach problems such as ulcers or kidney or liver disease.
-
you should know that choline magnesium trisalicylate should not be taken by children and teenagers with chicken pox or the flu, because of the risk of Reye Syndrome, a rare but serious disease.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking choline magnesium trisalicylate, call your doctor.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking choline magnesium trisalicylate.
-
ask your doctor about the safe use of alcoholic beverages while you are taking choline magnesium trisalicylate. Alcohol can make the side effects from choline magnesium trisalicylate worse.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Choline magnesium trisalicylate may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
upset stomach
-
vomiting
-
heartburn
-
diarrhea
-
constipation
-
stomach pain
-
headache
-
lightheadedness
-
dizziness
-
drowsiness
-
lack of energy
-
-
Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:
-
ringing in the ears
-
hearing loss
-
black and tarry stools
-
red blood in stools
-
bloody vomit
-
vomiting material that looks like coffee grounds
-
-
Choline magnesium trisalicylate may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include:
-
headache
-
dizziness
-
ringing in the ears
-
hearing loss
-
confusion
-
drowsiness
-
sweating
-
vomiting
-
diarrhea
-
rapid breathing
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to choline magnesium trisalicylate.
Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking choline magnesium trisalicylate.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Moxifloxacin | Moxifloxacin Choline magnesium trisalicylate may increase the neuroexcitatory activities of Moxifloxacin. |
Alendronate | Alendronate The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Alendronic acid. |
Anagrelide | Anagrelide The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Anagrelide. |
Candesartan | Candesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Choline magnesium trisalicylate. |
Cilostazol | Cilostazol The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Cilostazol. |
Clopidogrel | Clopidogrel The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Clopidogrel. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Choline magnesium trisalicylate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level. |
Fenofibrate | Fenofibrate Choline magnesium trisalicylate may decrease the excretion rate of Fenofibrate which could result in a higher serum level. |
Guanfacine | Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Choline magnesium trisalicylate. |
Magnesium Hydroxide | Magnesium Hydroxide Choline magnesium trisalicylate may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Methylergonovine | Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Choline magnesium trisalicylate. |
Mycophenolate | Mycophenolate Choline magnesium trisalicylate may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. |
Naratriptan | Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Choline magnesium trisalicylate. |
Olsalazine | Olsalazine The therapeutic efficacy of Olsalazine can be decreased when used in combination with Choline magnesium trisalicylate. |
Penbutolol | Penbutolol Choline magnesium trisalicylate may decrease the antihypertensive activities of Acebutolol. |
Potassium | Potassium Potassium cation may decrease the excretion rate of Choline magnesium trisalicylate which could result in a higher serum level. |
Prednisone | Prednisone The risk or severity of gastrointestinal irritation can be increased when Choline magnesium trisalicylate is combined with Prednisone. |
Ranitidine | Ranitidine Choline magnesium trisalicylate may decrease the excretion rate of Ranitidine which could result in a higher serum level. |
Reserpine | Reserpine The therapeutic efficacy of Reserpine can be decreased when used in combination with Choline magnesium trisalicylate. |
Rizatriptan | Rizatriptan Choline magnesium trisalicylate may decrease the excretion rate of Rizatriptan which could result in a higher serum level. |
Sumatriptan | Sumatriptan Choline magnesium trisalicylate may decrease the excretion rate of Sumatriptan which could result in a higher serum level. |
Tacrolimus | Tacrolimus The risk or severity of renal failure can be increased when Choline magnesium trisalicylate is combined with Tacrolimus. |
Tiludronate | Tiludronate The risk or severity of gastrointestinal bleeding can be increased when Choline magnesium trisalicylate is combined with Etidronic acid. |
Triamcinolone | Triamcinolone The risk or severity of gastrointestinal irritation can be increased when Triamcinolone is combined with Choline magnesium trisalicylate. |
Zolmitriptan | Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Choline magnesium trisalicylate. |
Ampicillin Injection | Ampicillin Injection Choline magnesium trisalicylate may decrease the excretion rate of Ampicillin which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Choline magnesium trisalicylate may decrease the excretion rate of Doxycycline which could result in a higher serum level. |
Fluconazole Injection | Fluconazole Injection Choline magnesium trisalicylate may decrease the excretion rate of Fluconazole which could result in a higher serum level. |
Foscarnet Injection | Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Foscarnet. |
Hydromorphone Injection | Hydromorphone Injection Choline magnesium trisalicylate may decrease the excretion rate of Hydromorphone which could result in a higher serum level. |
Levofloxacin Injection | Levofloxacin Injection Choline magnesium trisalicylate may decrease the excretion rate of Levofloxacin which could result in a higher serum level. |
Meperidine Injection | Meperidine Injection Choline magnesium trisalicylate may decrease the excretion rate of Meperidine which could result in a higher serum level. |
Methylprednisolone Injection | Methylprednisolone Injection The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Choline magnesium trisalicylate. |
Metoclopramide Injection | Metoclopramide Injection Choline magnesium trisalicylate may decrease the excretion rate of Metoclopramide which could result in a higher serum level. |
Pamidronate Injection | Pamidronate Injection The risk or severity of gastrointestinal bleeding can be increased when Choline magnesium trisalicylate is combined with Pamidronic acid. |
Vancomycin Injection | Vancomycin Injection Choline magnesium trisalicylate may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Zidovudine Injection | Zidovudine Injection The risk or severity of bleeding can be increased when Zidovudine is combined with Choline magnesium trisalicylate. |
Altretamine | Altretamine Choline magnesium trisalicylate may decrease the excretion rate of Amphetamine which could result in a higher serum level. |
Cefuroxime | Cefuroxime The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Choline magnesium trisalicylate. |
Cyclosporine | Cyclosporine The risk or severity of renal failure and hypertension can be increased when Choline magnesium trisalicylate is combined with Cyclosporine. |
Enoxaparin Injection | Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Enoxaparin. |
Torsemide | Torsemide The therapeutic efficacy of Torasemide can be decreased when used in combination with Choline magnesium trisalicylate. |
Eprosartan | Eprosartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Choline magnesium trisalicylate. |
Meloxicam | Meloxicam The risk or severity of adverse effects can be increased when Meloxicam is combined with Choline magnesium trisalicylate. |
Pantoprazole | Pantoprazole Choline magnesium trisalicylate may decrease the excretion rate of Pantoprazole which could result in a higher serum level. |
Risedronate | Risedronate The risk or severity of gastrointestinal bleeding can be increased when Choline magnesium trisalicylate is combined with Risedronic acid. |
Sevelamer | Sevelamer Sevelamer can cause a decrease in the absorption of Choline magnesium trisalicylate resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Telmisartan | Telmisartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Choline magnesium trisalicylate. |
Temozolomide | Temozolomide Choline magnesium trisalicylate may decrease the excretion rate of Temozolomide which could result in a higher serum level. |
Zaleplon | Zaleplon Choline magnesium trisalicylate may decrease the excretion rate of Zaleplon which could result in a higher serum level. |
Linezolid | Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Choline magnesium trisalicylate. |
Pentosan Polysulfate | Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Pentosan polysulfate. |
Trimipramine | Trimipramine The risk or severity of hypertension can be increased when Trimipramine is combined with Choline magnesium trisalicylate. |
Perindopril | Perindopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Perindopril. |
Tenofovir | Tenofovir Choline magnesium trisalicylate may increase the nephrotoxic activities of Tenofovir. |
Dutasteride | Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Choline magnesium trisalicylate. |
Epinephrine Injection | Epinephrine Injection The risk or severity of hypertension can be increased when Epinephrine is combined with Choline magnesium trisalicylate. |
Eplerenone | Eplerenone The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Eplerenone. |
Escitalopram | Escitalopram The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Choline magnesium trisalicylate. |
Olmesartan | Olmesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Choline magnesium trisalicylate. |
Zonisamide | Zonisamide Choline magnesium trisalicylate may decrease the excretion rate of Zonisamide which could result in a higher serum level. |
Aripiprazole | Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Choline magnesium trisalicylate. |
Atomoxetine | Atomoxetine Choline magnesium trisalicylate may decrease the excretion rate of Atomoxetine which could result in a higher serum level. |
Dexmethylphenidate | Dexmethylphenidate The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Dexmethylphenidate. |
Atazanavir | Atazanavir The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Choline magnesium trisalicylate. |
Almotriptan | Almotriptan Choline magnesium trisalicylate may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Eletriptan | Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Choline magnesium trisalicylate. |
Emtricitabine | Emtricitabine Choline magnesium trisalicylate may decrease the excretion rate of Emtricitabine which could result in a higher serum level. |
Memantine | Memantine Choline magnesium trisalicylate may decrease the excretion rate of Memantine which could result in a higher serum level. |
Tadalafil | Tadalafil Choline magnesium trisalicylate may decrease the excretion rate of Tadalafil which could result in a higher serum level. |
Frovatriptan | Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Choline magnesium trisalicylate. |
Gemifloxacin | Gemifloxacin Choline magnesium trisalicylate may increase the neuroexcitatory activities of Gemifloxacin. |
Protriptyline | Protriptyline The risk or severity of hypertension can be increased when Protriptyline is combined with Choline magnesium trisalicylate. |
Duloxetine | Duloxetine The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Choline magnesium trisalicylate. |
Tinidazole | Tinidazole Choline magnesium trisalicylate may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Bosentan | Bosentan The therapeutic efficacy of Bosentan can be decreased when used in combination with Choline magnesium trisalicylate. |
Cefditoren | Cefditoren Choline magnesium trisalicylate may decrease the excretion rate of Cefdinir which could result in a higher serum level. |
Cyanocobalamin Injection | Cyanocobalamin Injection Choline magnesium trisalicylate may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level. |
Eszopiclone | Eszopiclone Choline magnesium trisalicylate may decrease the excretion rate of Eszopiclone which could result in a higher serum level. |
Ganciclovir | Ganciclovir Choline magnesium trisalicylate may decrease the excretion rate of Ganciclovir which could result in a higher serum level. |
Ribavirin | Ribavirin Choline magnesium trisalicylate may decrease the excretion rate of Ribavirin which could result in a higher serum level. |
Solifenacin | Solifenacin The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Solifenacin. |
Valganciclovir | Valganciclovir Choline magnesium trisalicylate may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Zoledronic Acid Injection | Zoledronic Acid Injection The risk or severity of gastrointestinal bleeding can be increased when Choline magnesium trisalicylate is combined with Zoledronic acid. |
Adefovir | Adefovir The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Adefovir. |
Dextroamphetamine | Dextroamphetamine Choline magnesium trisalicylate may decrease the excretion rate of Amphetamine which could result in a higher serum level. |
Ibandronate | Ibandronate The risk or severity of gastrointestinal bleeding can be increased when Choline magnesium trisalicylate is combined with Ibandronate. |
Isocarboxazid | Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Choline magnesium trisalicylate. |
Ramelteon | Ramelteon Choline magnesium trisalicylate may decrease the excretion rate of Ramelteon which could result in a higher serum level. |
Fentanyl | Fentanyl Fentanyl may decrease the excretion rate of Choline magnesium trisalicylate which could result in a higher serum level. |
Pregabalin | Pregabalin Choline magnesium trisalicylate may decrease the excretion rate of Pregabalin which could result in a higher serum level. |
Deferasirox | Deferasirox The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Choline magnesium trisalicylate is combined with Deferasirox. |
Phenylephrine | Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Choline magnesium trisalicylate. |
Ranolazine | Ranolazine Choline magnesium trisalicylate may decrease the excretion rate of Ranolazine which could result in a higher serum level. |
Rasagiline | Rasagiline Choline magnesium trisalicylate may decrease the excretion rate of Rasagiline which could result in a higher serum level. |
Sitagliptin | Sitagliptin Choline magnesium trisalicylate may decrease the excretion rate of Sitagliptin which could result in a higher serum level. |
Varenicline | Varenicline Choline magnesium trisalicylate may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Albuterol | Albuterol Choline magnesium trisalicylate may decrease the excretion rate of Salbutamol which could result in a higher serum level. |
Paliperidone | Paliperidone Choline magnesium trisalicylate may decrease the excretion rate of Paliperidone which could result in a higher serum level. |
Clofarabine Injection | Clofarabine Injection Choline magnesium trisalicylate may decrease the excretion rate of Clofarabine which could result in a higher serum level. |
Lubiprostone | Lubiprostone Choline magnesium trisalicylate may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Aliskiren | Aliskiren The risk or severity of renal failure and hypertension can be increased when Choline magnesium trisalicylate is combined with Aliskiren. |
Bismuth Subsalicylate | Bismuth Subsalicylate The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Choline magnesium trisalicylate. |
Pemetrexed Injection | Pemetrexed Injection Choline magnesium trisalicylate may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Lisdexamfetamine | Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Choline magnesium trisalicylate. |
Sorafenib | Sorafenib Choline magnesium trisalicylate may decrease the excretion rate of Sorafenib which could result in a higher serum level. |
Levocetirizine | Levocetirizine Choline magnesium trisalicylate may decrease the excretion rate of Levocetirizine which could result in a higher serum level. |
Pegaptanib Injection | Pegaptanib Injection Choline magnesium trisalicylate may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Azacitidine Injection | Azacitidine Injection Choline magnesium trisalicylate may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Lenalidomide | Lenalidomide Choline magnesium trisalicylate may decrease the excretion rate of Lenalidomide which could result in a higher serum level. |
Budesonide | Budesonide The risk or severity of gastrointestinal irritation can be increased when Choline magnesium trisalicylate is combined with Budesonide. |
Desmopressin | Desmopressin The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Choline magnesium trisalicylate is combined with Desmopressin. |
Doripenem Injection | Doripenem Injection Choline magnesium trisalicylate may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection Choline magnesium trisalicylate may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level. |
Desvenlafaxine | Desvenlafaxine The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Choline magnesium trisalicylate. |
Cevimeline | Cevimeline Choline magnesium trisalicylate may decrease the excretion rate of Cevimeline which could result in a higher serum level. |
Nebivolol | Nebivolol Choline magnesium trisalicylate may decrease the antihypertensive activities of Nebivolol. |
Certolizumab Injection | Certolizumab Injection Choline magnesium trisalicylate may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level. |
Daptomycin Injection | Daptomycin Injection Choline magnesium trisalicylate may decrease the excretion rate of Daptomycin which could result in a higher serum level. |
Methylnaltrexone Injection | Methylnaltrexone Injection Choline magnesium trisalicylate may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Midazolam | Midazolam Choline magnesium trisalicylate may decrease the excretion rate of Midazolam which could result in a higher serum level. |
Dexrazoxane Injection | Dexrazoxane Injection Choline magnesium trisalicylate may decrease the excretion rate of Dexrazoxane which could result in a higher serum level. |
Milnacipran | Milnacipran The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Choline magnesium trisalicylate. |
Plerixafor Injection | Plerixafor Injection Choline magnesium trisalicylate may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Sodium Phosphate | Sodium Phosphate The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Choline magnesium trisalicylate. |
Fesoterodine | Fesoterodine Choline magnesium trisalicylate may decrease the excretion rate of Fesoterodine which could result in a higher serum level. |
Betaxolol | Betaxolol Choline magnesium trisalicylate may decrease the antihypertensive activities of Betaxolol. |
Iloperidone | Iloperidone The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Iloperidone. |
Prasugrel | Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Prasugrel. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) The risk or severity of hyperkalemia can be increased when Choline magnesium trisalicylate is combined with Tolvaptan. |
Dronedarone | Dronedarone The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Dronedarone. |
Pralatrexate Injection | Pralatrexate Injection Choline magnesium trisalicylate may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection Choline magnesium trisalicylate may decrease the excretion rate of Palonosetron which could result in a higher serum level. |
Saxagliptin | Saxagliptin Choline magnesium trisalicylate may decrease the excretion rate of Saxagliptin which could result in a higher serum level. |
Telavancin Injection | Telavancin Injection Choline magnesium trisalicylate may decrease the excretion rate of Telavancin which could result in a higher serum level. |
Topotecan | Topotecan Choline magnesium trisalicylate may decrease the excretion rate of Topotecan which could result in a higher serum level. |
Asenapine | Asenapine The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Asenapine. |
Dabigatran | Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Dabigatran. |
Dalfampridine | Dalfampridine Choline magnesium trisalicylate may decrease the excretion rate of Dalfampridine which could result in a higher serum level. |
Ceftaroline Injection | Ceftaroline Injection The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Ceftaroline fosamil. |
Lurasidone | Lurasidone The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection The risk or severity of adverse effects can be increased when Acetaminophen is combined with Choline magnesium trisalicylate. |
Vilazodone | Vilazodone The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Vilazodone. |
Ipilimumab Injection | Ipilimumab Injection Choline magnesium trisalicylate may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Choline magnesium trisalicylate may decrease the excretion rate of Aldesleukin which could result in a higher serum level. |
Terbutaline Injection | Terbutaline Injection Choline magnesium trisalicylate may decrease the excretion rate of Terbutaline which could result in a higher serum level. |
Azilsartan | Azilsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Choline magnesium trisalicylate. |
Roflumilast | Roflumilast Choline magnesium trisalicylate may decrease the excretion rate of Roflumilast which could result in a higher serum level. |
Potassium Iodide | Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Choline magnesium trisalicylate. |
Rivaroxaban | Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Rivaroxaban. |
Ticagrelor | Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Ticagrelor. |
Ruxolitinib | Ruxolitinib Choline magnesium trisalicylate may decrease the excretion rate of Ruxolitinib which could result in a higher serum level. |
Clobazam | Clobazam Choline magnesium trisalicylate may decrease the excretion rate of Clobazam which could result in a higher serum level. |
Deferiprone | Deferiprone Choline magnesium trisalicylate may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Cabergoline | Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Choline magnesium trisalicylate. |
Naloxone Injection | Naloxone Injection Choline magnesium trisalicylate may decrease the excretion rate of Naloxone which could result in a higher serum level. |
Ambrisentan | Ambrisentan The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Choline magnesium trisalicylate. |
Fondaparinux Injection | Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Fondaparinux. |
Iloprost | Iloprost The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Iloprost. |
Enzalutamide | Enzalutamide Choline magnesium trisalicylate may decrease the excretion rate of Enzalutamide which could result in a higher serum level. |
Mirabegron | Mirabegron Choline magnesium trisalicylate may decrease the excretion rate of Mirabegron which could result in a higher serum level. |
Corticotropin, Repository Injection | Corticotropin, Repository Injection The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Choline magnesium trisalicylate. |
Teduglutide Injection | Teduglutide Injection Choline magnesium trisalicylate may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Icosapent Ethyl | Icosapent Ethyl The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Icosapent ethyl. |
Alogliptin | Alogliptin Choline magnesium trisalicylate may decrease the excretion rate of Alogliptin which could result in a higher serum level. |
Pomalidomide | Pomalidomide Choline magnesium trisalicylate may decrease the excretion rate of Pomalidomide which could result in a higher serum level. |
Apixaban | Apixaban The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Apixaban. |
Canagliflozin | Canagliflozin Choline magnesium trisalicylate may decrease the excretion rate of Canagliflozin which could result in a higher serum level. |
Trametinib | Trametinib Choline magnesium trisalicylate may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Choline magnesium trisalicylate. |
Ertapenem Injection | Ertapenem Injection Choline magnesium trisalicylate may decrease the excretion rate of Ertapenem which could result in a higher serum level. |
Vortioxetine | Vortioxetine Choline magnesium trisalicylate may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ketorolac Injection | Ketorolac Injection The risk or severity of adverse effects can be increased when Ketorolac is combined with Choline magnesium trisalicylate. |
Sofosbuvir | Sofosbuvir Choline magnesium trisalicylate may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Apremilast | Apremilast Choline magnesium trisalicylate may decrease the excretion rate of Apremilast which could result in a higher serum level. |
Droxidopa | Droxidopa Choline magnesium trisalicylate may decrease the excretion rate of Droxidopa which could result in a higher serum level. |
Testosterone Injection | Testosterone Injection Choline magnesium trisalicylate may decrease the excretion rate of Testosterone which could result in a higher serum level. |
Vorapaxar | Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Vorapaxar. |
Edoxaban | Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Edoxaban. |
Methamphetamine | Methamphetamine Choline magnesium trisalicylate may decrease the excretion rate of Metamfetamine which could result in a higher serum level. |
Tasimelteon | Tasimelteon Choline magnesium trisalicylate may decrease the excretion rate of Tasimelteon which could result in a higher serum level. |
Riociguat | Riociguat The therapeutic efficacy of Riociguat can be decreased when used in combination with Choline magnesium trisalicylate. |
Risperidone Injection | Risperidone Injection The risk or severity of hypertension can be increased when Risperidone is combined with Choline magnesium trisalicylate. |
Haloperidol Injection | Haloperidol Injection The therapeutic efficacy of Haloperidol can be increased when used in combination with Choline magnesium trisalicylate. |
Amiloride | Amiloride The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Amiloride. |
Macitentan | Macitentan The therapeutic efficacy of Macitentan can be decreased when used in combination with Choline magnesium trisalicylate. |
Flibanserin | Flibanserin The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Flibanserin. |
Prednisolone | Prednisolone The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Choline magnesium trisalicylate. |
Brexpiprazole | Brexpiprazole The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of hypertension can be increased when Ziprasidone is combined with Choline magnesium trisalicylate. |
Cariprazine | Cariprazine The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Cariprazine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Choline magnesium trisalicylate may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Ixazomib | Ixazomib Choline magnesium trisalicylate may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Lesinurad | Lesinurad Choline magnesium trisalicylate may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Choline magnesium trisalicylate. |
Dexamethasone Injection | Dexamethasone Injection The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Choline magnesium trisalicylate. |
Defibrotide Injection | Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Defibrotide. |
Brivaracetam Injection | Brivaracetam Injection Choline magnesium trisalicylate may decrease the excretion rate of Brivaracetam which could result in a higher serum level. |
Midodrine | Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Choline magnesium trisalicylate. |
Selexipag | Selexipag The therapeutic efficacy of Selexipag can be decreased when used in combination with Choline magnesium trisalicylate. |
Furosemide Injection | Furosemide Injection The therapeutic efficacy of Furosemide can be decreased when used in combination with Choline magnesium trisalicylate. |
Lixisenatide Injection | Lixisenatide Injection Choline magnesium trisalicylate may decrease the excretion rate of Lixisenatide which could result in a higher serum level. |
Doxepin (Insomnia) | Doxepin (Insomnia) Doxepin may decrease the excretion rate of Choline magnesium trisalicylate which could result in a higher serum level. |
Deutetrabenazine | Deutetrabenazine Choline magnesium trisalicylate may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level. |
Valbenazine | Valbenazine Choline magnesium trisalicylate may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Deflazacort | Deflazacort The risk or severity of gastrointestinal irritation can be increased when Deflazacort is combined with Choline magnesium trisalicylate. |
Safinamide | Safinamide The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Safinamide. |
Naldemedine | Naldemedine Choline magnesium trisalicylate may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Benznidazole | Benznidazole Choline magnesium trisalicylate may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Delafloxacin | Delafloxacin Choline magnesium trisalicylate may decrease the excretion rate of Delafloxacin which could result in a higher serum level. |
Betrixaban | Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Choline magnesium trisalicylate. |
Apalutamide | Apalutamide Choline magnesium trisalicylate may decrease the excretion rate of Apalutamide which could result in a higher serum level. |
Baricitinib | Baricitinib Choline magnesium trisalicylate may decrease the excretion rate of Baricitinib which could result in a higher serum level. |
Lofexidine | Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Choline magnesium trisalicylate. |
Plazomicin Injection | Plazomicin Injection Choline magnesium trisalicylate may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Cannabidiol | Cannabidiol The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Cannabidiol. |
Stiripentol | Stiripentol Choline magnesium trisalicylate may decrease the excretion rate of Stiripentol which could result in a higher serum level. |
Prucalopride | Prucalopride Choline magnesium trisalicylate may decrease the excretion rate of Prucalopride which could result in a higher serum level. |
Siponimod | Siponimod The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Siponimod. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Choline magnesium trisalicylate may decrease the excretion rate of Acyclovir which could result in a higher serum level. |
Caplacizumab-yhdp Injection | Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Caplacizumab. |
Solriamfetol | Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Choline magnesium trisalicylate. |
Pitolisant | Pitolisant The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Pitolisant. |
Phenytoin Injection | Phenytoin Injection The serum concentration of Phenytoin can be increased when it is combined with Choline magnesium trisalicylate. |
Selpercatinib | Selpercatinib The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Selpercatinib. |
Naxitamab-gqgk Injection | Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Naxitamab. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Choline magnesium trisalicylate is combined with Drospirenone. |
Viloxazine | Viloxazine Choline magnesium trisalicylate may decrease the excretion rate of Viloxazine which could result in a higher serum level. |
Tobramycin Injection | Tobramycin Injection Choline magnesium trisalicylate may decrease the excretion rate of Tobramycin which could result in a higher serum level. |
Fenoprofen | Fenoprofen The risk or severity of adverse effects can be increased when Fenoprofen is combined with Choline magnesium trisalicylate. |
Indomethacin | Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Choline magnesium trisalicylate. |
Mefenamic Acid | Mefenamic Acid The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Choline magnesium trisalicylate. |
Naproxen | Naproxen The risk or severity of adverse effects can be increased when Naproxen is combined with Choline magnesium trisalicylate. |
Tolmetin | Tolmetin The risk or severity of adverse effects can be increased when Tolmetin is combined with Choline magnesium trisalicylate. |
Sulindac | Sulindac The risk or severity of adverse effects can be increased when Sulindac is combined with Choline magnesium trisalicylate. |
Trazodone | Trazodone The risk or severity of gastrointestinal bleeding can be increased when Trazodone is combined with Choline magnesium trisalicylate. |
Isotretinoin | Isotretinoin Choline magnesium trisalicylate may decrease the excretion rate of Isotretinoin which could result in a higher serum level. |
Sucralfate | Sucralfate Choline magnesium trisalicylate may decrease the excretion rate of Sucralfate which could result in a higher serum level. |
Floxuridine | Floxuridine Choline magnesium trisalicylate may decrease the excretion rate of Floxuridine which could result in a higher serum level. |
Metaxalone | Metaxalone Choline magnesium trisalicylate may decrease the excretion rate of Metaxalone which could result in a higher serum level. |
Methotrexate Injection | Methotrexate Injection The serum concentration of Methotrexate can be increased when it is combined with Choline magnesium trisalicylate. |
Methsuximide | Methsuximide The risk or severity of hyperkalemia can be increased when Choline magnesium trisalicylate is combined with Methsuximide. |
Diethylpropion | Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Choline magnesium trisalicylate. |
Chlorpromazine | Chlorpromazine Choline magnesium trisalicylate may decrease the excretion rate of Chlorpromazine which could result in a higher serum level. |
Diazepam | Diazepam Choline magnesium trisalicylate may decrease the excretion rate of Diazepam which could result in a higher serum level. |
Oxazepam | Oxazepam Choline magnesium trisalicylate may decrease the excretion rate of Oxazepam which could result in a higher serum level. |
Flurazepam | Flurazepam Choline magnesium trisalicylate may decrease the excretion rate of Flurazepam which could result in a higher serum level. |
Clorazepate | Clorazepate Choline magnesium trisalicylate may decrease the excretion rate of Clorazepic acid which could result in a higher serum level. |
Lorazepam | Lorazepam Choline magnesium trisalicylate may decrease the excretion rate of Lorazepam which could result in a higher serum level. |
Phenoxybenzamine | Phenoxybenzamine The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Choline magnesium trisalicylate. |
Carmustine | Carmustine Choline magnesium trisalicylate may decrease the excretion rate of Carmustine which could result in a higher serum level. |
Amantadine | Amantadine Choline magnesium trisalicylate may decrease the excretion rate of Amantadine which could result in a higher serum level. |
Codeine | Codeine Choline magnesium trisalicylate may decrease the excretion rate of Codeine which could result in a higher serum level. |
Bromocriptine | Bromocriptine The risk or severity of hypertension can be increased when Bromocriptine is combined with Choline magnesium trisalicylate. |
Metaproterenol | Metaproterenol The risk or severity of hypertension can be increased when Orciprenaline is combined with Choline magnesium trisalicylate. |
Tranylcypromine | Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Choline magnesium trisalicylate. |
Phenelzine | Phenelzine Choline magnesium trisalicylate may decrease the excretion rate of Phenelzine which could result in a higher serum level. |
Ergoloid Mesylates | Ergoloid Mesylates The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Choline magnesium trisalicylate. |
Tetracycline | Tetracycline Choline magnesium trisalicylate may decrease the excretion rate of Tetracycline which could result in a higher serum level. |
Thioridazine | Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Choline magnesium trisalicylate. |
Trifluoperazine | Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Choline magnesium trisalicylate. |
Bleomycin | Bleomycin Choline magnesium trisalicylate may decrease the excretion rate of Bleomycin which could result in a higher serum level. |
Sulfadiazine | Sulfadiazine Choline magnesium trisalicylate may decrease the excretion rate of Sulfadiazine which could result in a higher serum level. |
Methadone | Methadone Choline magnesium trisalicylate may decrease the excretion rate of Methadone which could result in a higher serum level. |
Benztropine | Benztropine Choline magnesium trisalicylate may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Colestipol | Colestipol Colestipol can cause a decrease in the absorption of Choline magnesium trisalicylate resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Maprotiline | Maprotiline Choline magnesium trisalicylate may decrease the excretion rate of Maprotiline which could result in a higher serum level. |
Ibuprofen | Ibuprofen The risk or severity of adverse effects can be increased when Ibuprofen is combined with Choline magnesium trisalicylate. |
Azathioprine | Azathioprine Choline magnesium trisalicylate may decrease the excretion rate of Azathioprine which could result in a higher serum level. |
Phentermine | Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Choline magnesium trisalicylate. |
Methylphenidate | Methylphenidate Choline magnesium trisalicylate may decrease the excretion rate of Methylphenidate which could result in a higher serum level. |
Amoxapine | Amoxapine The risk or severity of hypertension can be increased when Amoxapine is combined with Choline magnesium trisalicylate. |
Sulfasalazine | Sulfasalazine The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Choline magnesium trisalicylate. |
Hydrocortisone | Hydrocortisone The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Choline magnesium trisalicylate. |
Phenazopyridine | Phenazopyridine The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Phenazopyridine. |
Carbamazepine | Carbamazepine Choline magnesium trisalicylate may decrease the excretion rate of Carbamazepine which could result in a higher serum level. |
Methyldopa | Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Choline magnesium trisalicylate. |
Clonidine | Clonidine The therapeutic efficacy of Clonidine can be decreased when used in combination with Choline magnesium trisalicylate. |
Prazosin | Prazosin The therapeutic efficacy of Prazosin can be decreased when used in combination with Choline magnesium trisalicylate. |
Hydralazine | Hydralazine Choline magnesium trisalicylate may decrease the antihypertensive activities of Hydralazine. |
Cimetidine | Cimetidine Choline magnesium trisalicylate may decrease the excretion rate of Cimetidine which could result in a higher serum level. |
Gentamicin Injection | Gentamicin Injection Choline magnesium trisalicylate may decrease the excretion rate of Gentamicin which could result in a higher serum level. |
Warfarin | Warfarin The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Warfarin. |
Clonazepam | Clonazepam Choline magnesium trisalicylate may decrease the excretion rate of Clonazepam which could result in a higher serum level. |
Loperamide | Loperamide The risk or severity of hyperkalemia can be increased when Loperamide is combined with Choline magnesium trisalicylate. |
Promethazine | Promethazine Choline magnesium trisalicylate may decrease the excretion rate of Promethazine which could result in a higher serum level. |
Meclofenamate | Meclofenamate The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Choline magnesium trisalicylate. |
Nitrofurantoin | Nitrofurantoin Choline magnesium trisalicylate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Digoxin | Digoxin Choline magnesium trisalicylate may decrease the excretion rate of Digoxin which could result in a higher serum level. |
Chloroquine | Chloroquine Choline magnesium trisalicylate may decrease the excretion rate of Chloroquine which could result in a higher serum level. |
Ethosuximide | Ethosuximide The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Choline magnesium trisalicylate. |
Triamterene | Triamterene The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Triamterene. |
Sulfinpyrazone | Sulfinpyrazone The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Sulfinpyrazone. |
Chlorothiazide | Chlorothiazide The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Choline magnesium trisalicylate. |
Chlorthalidone | Chlorthalidone The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Choline magnesium trisalicylate. |
Metolazone | Metolazone The therapeutic efficacy of Metolazone can be decreased when used in combination with Choline magnesium trisalicylate. |
Secobarbital | Secobarbital Choline magnesium trisalicylate may decrease the excretion rate of Secobarbital which could result in a higher serum level. |
Desipramine | Desipramine Desipramine may decrease the excretion rate of Choline magnesium trisalicylate which could result in a higher serum level. |
Amitriptyline | Amitriptyline Amitriptyline may decrease the excretion rate of Choline magnesium trisalicylate which could result in a higher serum level. |
Imipramine | Imipramine Imipramine may decrease the excretion rate of Choline magnesium trisalicylate which could result in a higher serum level. |
Probenecid | Probenecid Probenecid may decrease the excretion rate of Choline magnesium trisalicylate which could result in a higher serum level. |
Quinidine | Quinidine Choline magnesium trisalicylate may decrease the excretion rate of Quinidine which could result in a higher serum level. |
Procainamide | Procainamide Choline magnesium trisalicylate may decrease the excretion rate of Procainamide which could result in a higher serum level. |
Isoniazid | Isoniazid Choline magnesium trisalicylate may decrease the excretion rate of Isoniazid which could result in a higher serum level. |
Pyrazinamide | Pyrazinamide Choline magnesium trisalicylate may decrease the excretion rate of Pyrazinamide which could result in a higher serum level. |
Disopyramide | Disopyramide Choline magnesium trisalicylate may decrease the excretion rate of Disopyramide which could result in a higher serum level. |
Valproic Acid | Valproic Acid The protein binding of Valproic acid can be decreased when combined with Choline magnesium trisalicylate. |
Butabarbital | Butabarbital Choline magnesium trisalicylate may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Liothyronine | Liothyronine Choline magnesium trisalicylate may decrease the excretion rate of Liothyronine which could result in a higher serum level. |
Methimazole | Methimazole Choline magnesium trisalicylate may decrease the excretion rate of Methimazole which could result in a higher serum level. |
Chlorpropamide | Chlorpropamide The protein binding of Chlorpropamide can be decreased when combined with Choline magnesium trisalicylate. |
Tolbutamide | Tolbutamide The protein binding of Tolbutamide can be decreased when combined with Choline magnesium trisalicylate. |
Tolazamide | Tolazamide The protein binding of Tolazamide can be decreased when combined with Choline magnesium trisalicylate. |
Baclofen | Baclofen Choline magnesium trisalicylate may decrease the excretion rate of Baclofen which could result in a higher serum level. |
Ethambutol | Ethambutol Choline magnesium trisalicylate may decrease the excretion rate of Ethambutol which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Choline magnesium trisalicylate. |
Hydrochlorothiazide | Hydrochlorothiazide The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Choline magnesium trisalicylate. |
Dantrolene | Dantrolene The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Choline magnesium trisalicylate. |
Chlorzoxazone | Chlorzoxazone Choline magnesium trisalicylate may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level. |
Pyridoxine | Pyridoxine Choline magnesium trisalicylate may decrease the excretion rate of Pyridoxine which could result in a higher serum level. |
Folic Acid | Folic Acid Choline magnesium trisalicylate may decrease the excretion rate of Folic acid which could result in a higher serum level. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) Choline magnesium trisalicylate may decrease the antihypertensive activities of Propranolol. |
Minoxidil | Minoxidil The therapeutic efficacy of Minoxidil can be decreased when used in combination with Choline magnesium trisalicylate. |
Pseudoephedrine | Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Choline magnesium trisalicylate. |
Nortriptyline | Nortriptyline The risk or severity of hypertension can be increased when Nortriptyline is combined with Choline magnesium trisalicylate. |
Spironolactone | Spironolactone The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Spironolactone. |
Amphotericin B Injection | Amphotericin B Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Choline magnesium trisalicylate. |
Phytonadione | Phytonadione Choline magnesium trisalicylate may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Choline magnesium trisalicylate may decrease the excretion rate of Amikacin which could result in a higher serum level. |
Nadolol | Nadolol Choline magnesium trisalicylate may decrease the antihypertensive activities of Nadolol. |
Cholestyramine Resin | Cholestyramine Resin Cholestyramine can cause a decrease in the absorption of Choline magnesium trisalicylate resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Allopurinol | Allopurinol Choline magnesium trisalicylate may decrease the excretion rate of Allopurinol which could result in a higher serum level. |
Flavoxate | Flavoxate Choline magnesium trisalicylate may decrease the excretion rate of Flavoxate which could result in a higher serum level. |
Colchicine | Colchicine Choline magnesium trisalicylate may decrease the excretion rate of Colchicine which could result in a higher serum level. |
Cefaclor | Cefaclor Choline magnesium trisalicylate may decrease the excretion rate of Cefaclor which could result in a higher serum level. |
Cefadroxil | Cefadroxil Choline magnesium trisalicylate may decrease the excretion rate of Cefadroxil which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Choline magnesium trisalicylate. |
Cephalexin | Cephalexin Choline magnesium trisalicylate may decrease the excretion rate of Cephalexin which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Choline magnesium trisalicylate. |
Dacarbazine | Dacarbazine Choline magnesium trisalicylate may decrease the excretion rate of Dacarbazine which could result in a higher serum level. |
Cefotaxime Injection | Cefotaxime Injection The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Choline magnesium trisalicylate. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Choline magnesium trisalicylate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level. |
Ketoconazole | Ketoconazole The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Choline magnesium trisalicylate. |
Pyrantel | Pyrantel Choline magnesium trisalicylate may decrease the excretion rate of Pyrantel which could result in a higher serum level. |
Captopril | Captopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Captopril. |
Dipyridamole | Dipyridamole The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Dipyridamole. |
Isoxsuprine | Isoxsuprine The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Isoxsuprine. |
Ethacrynic Acid | Ethacrynic Acid The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Choline magnesium trisalicylate. |
Colistimethate Injection | Colistimethate Injection The risk or severity of nephrotoxicity can be increased when Colistimethate is combined with Choline magnesium trisalicylate. |
Metoprolol | Metoprolol Choline magnesium trisalicylate may decrease the antihypertensive activities of Metoprolol. |
Aspirin | Aspirin The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Choline magnesium trisalicylate. |
Salsalate | Salsalate The risk or severity of adverse effects can be increased when Salsalate is combined with Choline magnesium trisalicylate. |
Alprazolam | Alprazolam Choline magnesium trisalicylate may decrease the excretion rate of Alprazolam which could result in a higher serum level. |
Temazepam | Temazepam Choline magnesium trisalicylate may decrease the excretion rate of Temazepam which could result in a higher serum level. |
Triazolam | Triazolam Choline magnesium trisalicylate may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dicyclomine | Dicyclomine Choline magnesium trisalicylate may decrease the excretion rate of Dicyclomine which could result in a higher serum level. |
Propantheline | Propantheline Choline magnesium trisalicylate may decrease the excretion rate of Propantheline which could result in a higher serum level. |
Trimethoprim | Trimethoprim Choline magnesium trisalicylate may decrease the excretion rate of Trimethoprim which could result in a higher serum level. |
Diltiazem | Diltiazem The therapeutic efficacy of Diltiazem can be decreased when used in combination with Choline magnesium trisalicylate. |
Nifedipine | Nifedipine Choline magnesium trisalicylate may decrease the excretion rate of Nifedipine which could result in a higher serum level. |
Timolol | Timolol Choline magnesium trisalicylate may decrease the antihypertensive activities of Timolol. |
Verapamil | Verapamil Choline magnesium trisalicylate may decrease the excretion rate of Verapamil which could result in a higher serum level. |
Atenolol | Atenolol Choline magnesium trisalicylate may decrease the antihypertensive activities of Atenolol. |
Pindolol | Pindolol Choline magnesium trisalicylate may decrease the antihypertensive activities of Pindolol. |
Cisplatin Injection | Cisplatin Injection Choline magnesium trisalicylate may decrease the excretion rate of Cisplatin which could result in a higher serum level. |
Diflunisal | Diflunisal The therapeutic efficacy of Diflunisal can be decreased when used in combination with Choline magnesium trisalicylate. |
Piroxicam | Piroxicam The risk or severity of adverse effects can be increased when Piroxicam is combined with Choline magnesium trisalicylate. |
Bumetanide | Bumetanide The therapeutic efficacy of Bumetanide can be decreased when used in combination with Choline magnesium trisalicylate. |
Glyburide | Glyburide The protein binding of Glyburide can be decreased when combined with Choline magnesium trisalicylate. |
Glipizide | Glipizide The protein binding of Glipizide can be decreased when combined with Choline magnesium trisalicylate. |
Indapamide | Indapamide The therapeutic efficacy of Indapamide can be decreased when used in combination with Choline magnesium trisalicylate. |
Amoxicillin | Amoxicillin Choline magnesium trisalicylate may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Choline magnesium trisalicylate may decrease the excretion rate of Oxacillin which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Pentoxifylline. |
Pentamidine Injection | Pentamidine Injection The risk or severity of nephrotoxicity can be increased when Pentamidine is combined with Choline magnesium trisalicylate. |
Ceftriaxone Injection | Ceftriaxone Injection Choline magnesium trisalicylate may decrease the excretion rate of Ceftriaxone which could result in a higher serum level. |
Labetalol | Labetalol Choline magnesium trisalicylate may decrease the antihypertensive activities of Labetalol. |
Auranofin | Auranofin Choline magnesium trisalicylate may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection Choline magnesium trisalicylate may decrease the excretion rate of Leuprolide which could result in a higher serum level. |
Gemfibrozil | Gemfibrozil Choline magnesium trisalicylate may decrease the excretion rate of Gemfibrozil which could result in a higher serum level. |
Guanabenz | Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Choline magnesium trisalicylate. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Choline magnesium trisalicylate. |
Ceftazidime Injection | Ceftazidime Injection Choline magnesium trisalicylate may decrease the excretion rate of Ceftazidime which could result in a higher serum level. |
Ketoprofen | Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Choline magnesium trisalicylate. |
Cefotetan Injection | Cefotetan Injection Choline magnesium trisalicylate may decrease the excretion rate of Cefotetan which could result in a higher serum level. |
Enalapril | Enalapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Enalapril. |
Flurbiprofen | Flurbiprofen The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Choline magnesium trisalicylate. |
Amiodarone | Amiodarone The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Choline magnesium trisalicylate. |
Aztreonam Injection | Aztreonam Injection Choline magnesium trisalicylate may decrease the excretion rate of Aztreonam which could result in a higher serum level. |
Buspirone | Buspirone Choline magnesium trisalicylate may decrease the excretion rate of Buspirone which could result in a higher serum level. |
Ciprofloxacin | Ciprofloxacin Choline magnesium trisalicylate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. |
Mesalamine | Mesalamine The therapeutic efficacy of Mesalazine can be decreased when used in combination with Choline magnesium trisalicylate. |
Diclofenac | Diclofenac The risk or severity of adverse effects can be increased when Diclofenac is combined with Choline magnesium trisalicylate. |
Fluoxetine | Fluoxetine The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Choline magnesium trisalicylate. |
Nimodipine | Nimodipine The therapeutic efficacy of Nimodipine can be decreased when used in combination with Choline magnesium trisalicylate. |
Clozapine | Clozapine Choline magnesium trisalicylate may decrease the excretion rate of Clozapine which could result in a higher serum level. |
Estazolam | Estazolam Choline magnesium trisalicylate may decrease the excretion rate of Estazolam which could result in a higher serum level. |
Ofloxacin | Ofloxacin Choline magnesium trisalicylate may increase the neuroexcitatory activities of Ofloxacin. |
Didanosine | Didanosine Choline magnesium trisalicylate may decrease the excretion rate of Didanosine which could result in a higher serum level. |
Pentostatin Injection | Pentostatin Injection Choline magnesium trisalicylate may decrease the excretion rate of Pentostatin which could result in a higher serum level. |
Benazepril | Benazepril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Benazepril. |
Etodolac | Etodolac The risk or severity of adverse effects can be increased when Etodolac is combined with Choline magnesium trisalicylate. |
Felodipine | Felodipine The therapeutic efficacy of Felodipine can be decreased when used in combination with Choline magnesium trisalicylate. |
Fosinopril | Fosinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Fosinopril. |
Nabumetone | Nabumetone The risk or severity of adverse effects can be increased when Nabumetone is combined with Choline magnesium trisalicylate. |
Quinapril | Quinapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Quinapril. |
Ramipril | Ramipril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Ramipril. |
Amlodipine | Amlodipine Choline magnesium trisalicylate may decrease the antihypertensive activities of Amlodipine. |
Itraconazole | Itraconazole The risk or severity of hyperkalemia can be increased when Itraconazole is combined with Choline magnesium trisalicylate. |
Lisinopril | Lisinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Lisinopril. |
Oxaprozin | Oxaprozin The risk or severity of adverse effects can be increased when Oxaprozin is combined with Choline magnesium trisalicylate. |
Sotalol | Sotalol Choline magnesium trisalicylate may decrease the antihypertensive activities of Sotalol. |
Bisoprolol | Bisoprolol Choline magnesium trisalicylate may decrease the antihypertensive activities of Bisoprolol. |
Doxazosin | Doxazosin The therapeutic efficacy of Doxazosin can be decreased when used in combination with Choline magnesium trisalicylate. |
Terazosin | Terazosin The therapeutic efficacy of Terazosin can be decreased when used in combination with Choline magnesium trisalicylate. |
Isradipine | Isradipine The therapeutic efficacy of Isradipine can be decreased when used in combination with Choline magnesium trisalicylate. |
Venlafaxine | Venlafaxine Venlafaxine may increase the antiplatelet activities of Choline magnesium trisalicylate. |
Fluvoxamine | Fluvoxamine The risk or severity of gastrointestinal bleeding can be increased when Choline magnesium trisalicylate is combined with Fluvoxamine. |
Nefazodone | Nefazodone The risk or severity of gastrointestinal bleeding can be increased when Choline magnesium trisalicylate is combined with Nefazodone. |
Lamotrigine | Lamotrigine Choline magnesium trisalicylate may decrease the excretion rate of Lamotrigine which could result in a higher serum level. |
Losartan | Losartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Choline magnesium trisalicylate. |
Valacyclovir | Valacyclovir Choline magnesium trisalicylate may decrease the excretion rate of Valaciclovir which could result in a higher serum level. |
Tramadol | Tramadol Choline magnesium trisalicylate may decrease the excretion rate of Tramadol which could result in a higher serum level. |
Carboplatin Injection | Carboplatin Injection Choline magnesium trisalicylate may decrease the excretion rate of Carboplatin which could result in a higher serum level. |
Moexipril | Moexipril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Moexipril. |
Ifosfamide Injection | Ifosfamide Injection Choline magnesium trisalicylate may decrease the excretion rate of Ifosfamide which could result in a higher serum level. |
Nicardipine | Nicardipine The therapeutic efficacy of Nicardipine can be decreased when used in combination with Choline magnesium trisalicylate. |
Bupropion | Bupropion Choline magnesium trisalicylate may decrease the excretion rate of Bupropion which could result in a higher serum level. |
Ticlopidine | Ticlopidine The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Ticlopidine. |
Metformin | Metformin Choline magnesium trisalicylate may decrease the excretion rate of Metformin which could result in a higher serum level. |
Dalteparin Injection | Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Dalteparin. |
Nisoldipine | Nisoldipine The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Choline magnesium trisalicylate. |
Lamivudine | Lamivudine Choline magnesium trisalicylate may decrease the excretion rate of Lamivudine which could result in a higher serum level. |
Acarbose | Acarbose Choline magnesium trisalicylate may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Glimepiride | Glimepiride The protein binding of Glimepiride can be decreased when combined with Choline magnesium trisalicylate. |
Gemcitabine Injection | Gemcitabine Injection Choline magnesium trisalicylate may decrease the excretion rate of Gemcitabine which could result in a higher serum level. |
Cidofovir Injection | Cidofovir Injection Choline magnesium trisalicylate may decrease the excretion rate of Cidofovir which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Choline magnesium trisalicylate may decrease the excretion rate of Meropenem which could result in a higher serum level. |
Clomipramine | Clomipramine Clomipramine may decrease the excretion rate of Choline magnesium trisalicylate which could result in a higher serum level. |
Fosfomycin | Fosfomycin Choline magnesium trisalicylate may decrease the excretion rate of Fosfomycin which could result in a higher serum level. |
Mirtazapine | Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Choline magnesium trisalicylate. |
Trandolapril | Trandolapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Trandolapril. |
Topiramate | Topiramate Choline magnesium trisalicylate may decrease the excretion rate of Topiramate which could result in a higher serum level. |
Valsartan | Valsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Choline magnesium trisalicylate. |
Pramipexole | Pramipexole Choline magnesium trisalicylate may decrease the excretion rate of Pramipexole which could result in a higher serum level. |
Carvedilol | Carvedilol Choline magnesium trisalicylate may decrease the antihypertensive activities of Carvedilol. |
Nilutamide | Nilutamide Choline magnesium trisalicylate may decrease the excretion rate of Nilutamide which could result in a higher serum level. |
Flutamide | Flutamide Choline magnesium trisalicylate may decrease the excretion rate of Flutamide which could result in a higher serum level. |
Selegiline | Selegiline The risk or severity of hypertension can be increased when Selegiline is combined with Choline magnesium trisalicylate. |
Sertraline | Sertraline The risk or severity of bleeding can be increased when Sertraline is combined with Choline magnesium trisalicylate. |
Propafenone | Propafenone Choline magnesium trisalicylate may decrease the antihypertensive activities of Propafenone. |
Irbesartan | Irbesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Choline magnesium trisalicylate. |
Tamsulosin | Tamsulosin Choline magnesium trisalicylate may decrease the excretion rate of Tamsulosin which could result in a higher serum level. |
Finasteride | Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Choline magnesium trisalicylate. |
Quetiapine | Quetiapine Choline magnesium trisalicylate may decrease the excretion rate of Quetiapine which could result in a higher serum level. |
Cefepime Injection | Cefepime Injection The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Cefepime. |
Cefprozil | Cefprozil The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Choline magnesium trisalicylate. |
Cefpodoxime | Cefpodoxime The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Cefpodoxime. |
Cetirizine | Cetirizine Choline magnesium trisalicylate may decrease the excretion rate of Cetirizine which could result in a higher serum level. |
Paroxetine | Paroxetine The risk or severity of gastrointestinal bleeding can be increased when Paroxetine is combined with Choline magnesium trisalicylate. |
Tolcapone | Tolcapone Choline magnesium trisalicylate may decrease the excretion rate of Tolcapone which could result in a higher serum level. |
Citalopram | Citalopram The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Choline magnesium trisalicylate. |
Capecitabine | Capecitabine Choline magnesium trisalicylate may decrease the excretion rate of Capecitabine which could result in a higher serum level. |
Abacavir | Abacavir Choline magnesium trisalicylate may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Celecoxib | Celecoxib The risk or severity of adverse effects can be increased when Celecoxib is combined with Choline magnesium trisalicylate. |
Rosiglitazone | Rosiglitazone Choline magnesium trisalicylate may decrease the excretion rate of Rosiglitazone which could result in a higher serum level. |
Tolterodine | Tolterodine Choline magnesium trisalicylate may decrease the excretion rate of Tolterodine which could result in a higher serum level. |
Oseltamivir | Oseltamivir Choline magnesium trisalicylate may decrease the excretion rate of Oseltamivir which could result in a higher serum level. |
Colesevelam | Colesevelam Colesevelam can cause a decrease in the absorption of Choline magnesium trisalicylate resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Balsalazide | Balsalazide The therapeutic efficacy of Balsalazide can be decreased when used in combination with Choline magnesium trisalicylate. |
Nateglinide | Nateglinide Choline magnesium trisalicylate may decrease the excretion rate of Nateglinide which could result in a higher serum level. |
Rabeprazole | Rabeprazole Choline magnesium trisalicylate may decrease the excretion rate of Rabeprazole which could result in a higher serum level. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists